King TD, Mills NL. Nonoperative closure of atrial septal defects. Surgery 1974; 75: 383–388.
Rashkind WJ. Experimental transvenous closure of atrial and ventricular septal defects. Circulation 1975; 52: II8.
Rashkind WJ. Transcatheter closure of atrial septal defects in children. Eur J Cardiol 1977; 8: 119–120.
Lock JE, Rome JJ, Davis R, et al. Transcatheter closure of atrial septal defects. Experimental studies. Circulation 1989; 79: 1091–1099.
Rome JJ, Keane JF, Perry SB, Spevak PJ, Lock JE. Double-umbrella closure of atrial defects. Initial clinical applications. [see comment]. Circulation 1990; 82: 751–758.
Sideris EB, Sideris SE, Thanopoulos BD, Ehly RL, Fowlkes JP. Transvenous atrial septal defect occlusion by the buttoned device. Am J Cardiol 1990; 66: 1524–1526.
Sideris EB, Sideris SE, Fowlkes JP, Ehly RL, Smith JE, Gulde RE. Transvenous atrial septal defect occlusion in piglets with a “buttoned” double-disk device. Circulation 1990; 81: 312–318.
Babic UU, Grujicic S, Djurisic Z, Vucinic M. Transcatheter closure of atrial septal defects. Lancet 1990; 336: 566–567.
Das GS, Voss G, Jarvis G, Wyche K, Gunther R, Wilson RF. Experimental atrial septal defect closure with a new, transcatheter, self-centering device. Circulation 1993; 88: 1754–1764.
Rickers C, Hamm C, Stern H, et al. Percutaneous closure of secundum atrial septal defect with a new self centering device (“angel wings”). Heart 1998; 80: 517–521.
Agarwal SK, Ghosh PK, Mittal PK. Failure of devices used for closure of atrial septal defects: mechanisms and management. J Thorac Cardiovasc Surg 1996; 112: 21–26.
Kay JD, O'Laughlin MP, Ito K, Wang A, Bashore TM, Harrison JK. Five-year clinical and echocardiographic evaluation of the Das AngelWings atrial septal occluder. Am Heart J 2004; 147: 361–368.
Carminati M, Giusti S, Hausdorf G, et al. A European multicentric experience using the CardioSEAL and Starflex double umbrella devices to close interatrial communications holes within the oval fossa. Cardiol Young 2000; 10: 519–526.
Bjørnstad PG, Smevik B, Fiane A, Tønnessen TI, Fosse E. Catheter-based closure of atrial septal defects with a newly developed nitinol double disc: an experimental study. Cardiol Young 1997; 7: 220–224.
Sharafuddin MJ, Gu X, Titus JL, Urness M, Cervera-Ceballos JJ, Amplatz K. Transvenous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model. [erratum appears in Circulation 1998 Feb 3; 97: 413]. Circulation 1997; 95: 2162–2168.
Bjørnstad PG, Masura J, Thaulow E, et al. Interventional closure of atrial septal defects with the Amplatzer device: first clinical experience. Cardiol Young 1997; 7: 277–283.
Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn 1997; 42: 388–393.
Berger F, Ewert P, Bjornstad PG, et al. Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer Septal Occluder [see comments]. Cardiol Young 1999; 9: 468–473.
Ewert P, Daehnert I, Berger F, et al. Transcatheter closure of atrial septal defects under echocardiographic guidance without X-ray: initial experiences. Cardiol Young 1999; 9: 136–140.
Kreutzer J, Ryan CA, Wright Jr JA, et al. Acute animal studies of the STARFlex system: a new self-centering cardioSEAL septal occluder. Cathet Cardiovasc Interv 2000; 49: 225–233.
Carminati M, Chessa M, Butera G, et al. Transcatheter closure of atrial septal defects with the STARFlex device: early results and follow-up. J Intervent Cardiol 2001; 14: 319–324.
Hausdorf G, Kaulitz R, Paul T, Carminati M, Lock J. Transcatheter closure of atrial septal defect with a new flexible, self-centering device (the STARFlex Occluder). Am J Cardiol 1999; 84: 1113–1116, A10.
Zahn EM, Wilson N, Cutright W, Latson LA. Development and testing of the Helex septal occluder, a new expanded polytetrafluoroethylene atrial septal defect occlusion system. Circulation 2001; 104: 711–716.
Söderberg B, Solymar L, Larsson M, Thommen D, Bernhard J, Östman-Smith I. The Solysafe septal occluder for atrial septal defects – animal testing of the improved design. Cardiol Young 2005; 15 (Suppl 2): II79.
Sideris EB, Sideris CE, Toumanides S, Moulopoulos SD. From disk devices to transcatheter patches: the evolution of wireless heart defect occlusion. J Intervent Cardiol 2001; 14: 211–214.
Sideris EB, Toumanides S, Macuil B, et al. Transcatheter patch correction of secundum atrial septal defects. Am J Cardiol 2002; 89: 1082–1086.
Wilkinson JL, Goh TH. Early clinical experience with use of the ‘Amplatzer Septal Occluder’ device for atrial septal defect. Cardiol Young 1998; 8: 295–302.
Pedra CA, Pihkala J, Lee KJ, et al. Transcatheter closure of atrial septal defects using the Cardio-Seal implant. Heart 2000; 84: 320–326.
Wang JK, Tsai SK, Wu MH, Lin MT, Lue HC. Short- and intermediate-term results of transcatheter closure of atrial septal defect with the Amplatzer Septal Occluder. Am Heart J 2004; 148: 511–517.
Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart 2003; 89: 199–204.
Rastegari M, Redington AN, Sullivan ID. Influence of the introduction of Amplatzer device on the interventional closure of defects within the oval fossa in children. Cardiol Young 2001; 11: 521–525.
Vogel M, Berger F, Dahnert I, Ewert P, Lange PE. Treatment of atrial septal defects in symptomatic children aged less than 2 years of age using the Amplatzer septal occluder. Cardiol Young 2000; 10: 534–537.
Bjørnstad PG, Holmstrøm H, Smevik B, Tønnessen TI, Fosse E. Transcatheter closure of atrial septal defects in the oval fossa. Is the method applicable in small children? Cardiol Young 2002; 12: 352–356.
Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects. Cathet Cardiovasc Interv 2004; 63: 496–502.
Kaulitz R, Paul T, Hausdorf G. Extending the limits of transcatheter closure of atrial septal defects with the double umbrella device (CardioSEAL). Heart 1998; 80: 54–59.
Hwang B, Lee PC, Fu YC, et al. Transcatheter closure of atrial septal defect with a CardioSEAL device. Jpn Heart J 2000; 41: 471–480.
Butera G, Carminati M, Chessa M, et al. CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defects. Am Heart J 2004; 148: 507–510.
Vincent RN, Raviele AA, Diehl HJ. Single-center experience with the HELEX septal occluder for closure of atrial septal defects in children. J Interv Cardiol 2003; 16: 79–82.
Pedra CA, Pedra SF, Esteves CA, et al. Initial experience in Brazil with the Helex septal occluder for percutaneous occlusion of atrial septal defects. Arq Brasil Cardiol 2003; 81: 435–452.
Hughes ML, Maskell G, Goh TH, Wilkinson JL. Prospective comparison of costs and short term health outcomes of surgical versus device closure of atrial septal defect in children. Heart 2002; 88: 67–70.
Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K, Amplatzer I. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 2002; 39: 1836–1844.
Miyaji K, Murakami A, Kobayashi J, Suematsu Y, Takamoto S. Transxiphoid approach for intracardiac repair using video-assisted cardioscopy. Ann Thorac Surg 2001; 71: 1716–1718.
Dabritz S, Sachweh J, Walter M, Messmer BJ. Closure of atrial septal defects via limited right anterolateral thoracotomy as a minimal invasive approach in female patients [see comment]. Eur J Cardiothorac Surg 1999; 15: 18–23.
Cremer JT, Boning A, Anssar MB, et al. Different approaches for minimally invasive closure of atrial septal defects [see comment]. Ann Thorac Surg 1999; 67: 1648–1652.
Black MD, Freedom RM. Minimally invasive repair of atrial septal defects. Ann Thorac Surg 1998; 65: 765–767.
Baskett RJ, Tancock E, Ross DB. The gold standard for atrial septal defect closure: current surgical results, with an emphasis on morbidity. Pediatr Cardiol 2003; 24: 444–447.
Hopkins RA, Bert AA, Buchholz B, Guarino K, Meyers M. Surgical patch closure of atrial septal defects. Ann Thorac Surg 2004; 77: 2144–2149.
Maeno YV, Benson LN, Boutin C. Impact of dynamic 3D transoesophageal echocardiography in the assessment of atrial septal defects and occlusion by the double-umbrella device (CardioSEAL). Cardiol Young 1998; 8: 368–378.
Prieto LR, Foreman CK, Cheatham JP, Latson LA. Intermediate-term outcome of transcatheter secundum atrial septal defect closure using the Bard Clamshell Septal Umbrella. Am J Cardiol 1996; 78: 1310–1312.
Hausdorf G, Schneider M, Fink C, et al. Transcatheter closure of atrial septal defects within the oval fossa: medium-term results in children using the ‘ASDOS’-technique. Cardiol Young 1998; 8: 462–471.
Sievert H, Babic UU, Hausdorf G, et al. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial). Am J Cardiol 1998; 82: 1405–1413.
Kong H, Wilkinson JL, Coe JY, et al. Corrosive behaviour of Amplatzer devices in experimental and biological environments. Cardiol Young 2002; 12: 260–265.
Ries MW, Kampmann C, Rupprecht HJ, Hintereder G, Hafner G, Meyer J. Nickel release after implantation of the Amplatzer occluder. Am Heart J 2003; 145: 737–741.
Pinto FF, Sousa L, Fragata J. Late cardiac tamponade after transcatheter closure of atrial septal defect with Cardioseal device. Cardiol Young 2001; 11: 233–235.
Preventza O, Sampath-Kumar S, Wasnick J, Gold JP. Late cardiac perforation following transcatheter atrial septal defect closure. Ann Thorac Surg 2004; 77: 1435–1437.
Mills NL, King TD. Late follow-up of nonoperative closure of secundum atrial septal defects using the King-Mills double-umbrella device. Am J Cardiol 2003; 92: 353–355.
Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1000 consecutive patients. J Am Coll Cardiol 2004; 43: 302–309.
Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol 2005; 45: 1213–1218.
Berger F, Vogel M, Alexi-Meskishvili V, Lange PE. Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg 1999; 118: 674–678.
Bialkowski J, Karwot B, Szkutnik M, Banaszak P, Kusa J, Skalski J. Closure of atrial septal defects in children: surgery versus Amplatzer device implantation. Tex Heart Inst J 2004; 31: 220–223.
Peuster M, Wohlsein P, Brugmann M, et al. A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal-results 6–18 months after implantation into New Zealand white rabbits. Heart 2001; 86: 563–569.
Jux C, Bertram H, Wohlsein P, et al. Experimental ASD closure using autologous cell-seeded interventional closure devices. Cardiovasc Res 2002; 53: 181–191.
Jux C, Wohlsein P, Bruegmann M, Zutz M, Franzbach B, Bertram H. New biological matrix for septal occlusion. J Interv Cardiol 2003; 16: 149–152.